Description

Composition

• BPC-157: 5mg ,10 mg
• TB-500 (Thymosin Beta 4): 10 mg
• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems
• Assay development, including chromatographic separation of two co-formulated peptides
• Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions

Documentation

• Lot-specific COA
• Batch and lot traceability

Important Notice

• For research use only
• Not for human consumption
• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Lot-specific COA
• Lyophilized for transit stability; batch traceable
• Tamper-evident seal; lot & test date on each vial
• No MOQ for online orders
• Bulk orders for physical locations start at 25-unit minimum